Basic Information
| RNALocate ID: | RLID:11003647 |
| RNA Symbol: | hsa-miR-30c-2-3p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-30c-2* |
| RNA ID: | miRBase:MIMAT0004550 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 21505438 |
| Tissue/Cell Line: | B cell line (Raji)|Jurkat-derived T cell line (J77cl20) |
| Method: | Microarray |
| Description: | Microarray analysis of exosomal miRNAs verses the miRNAs of their respective donor cells. Data are collected from Supplementary Data 1. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01002590 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:11003648 | Exosome | Plasma | 23663360 |
| RLID:11003649 | Microvesicle | Seminal plasma | 23539611 |
| RLID:11003650 | Microvesicle | Serum | 24797360 |
| RLID-D:11000597 | Microvesicle | Fibroblasts|Mesenchymal stem cells | |
| RLID-D:11001476 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-30c-2-3p | Oral squamous cell carcinoma | MNDR-E-MI-37184 |
| MNDR | hsa-miR-30c-2-3p | Large cell neuroendocrine cancer | MNDR-E-MI-37185 |
| MNDR | hsa-miR-30c-2-3p | Ovarian clear cell carcinoma | MNDR-E-MI-37186 |
| MNDR | hsa-miR-30c-2-3p | Uterine corpus endometrial carcinoma | MNDR-E-MI-37187 |
| MNDR | hsa-miR-30c-2-3p | Lymphoma | MNDR-E-MI-37188 |
| MNDR | hsa-miR-30c-2-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-37189 |
| MNDR | hsa-miR-30c-2-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-37190 |
| MNDR | hsa-miR-30c-2-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-37191 |
| MNDR | hsa-miR-30c-2-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-37192 |
| MNDR | hsa-miR-30c-2-3p | Her2-receptor positive breast cancer | MNDR-E-MI-37193 |
| MNDR | hsa-miR-30c-2-3p | Prostate cancer | MNDR-E-MI-37194 |
| MNDR | hsa-miR-30c-2-3p | Gastric cancer | MNDR-E-MI-37195 |
| MNDR | hsa-miR-30c-2-3p | Alzheimer disease | MNDR-E-MI-37196 |
| MNDR | hsa-miR-30c-2-3p | Intracranial aneurysm | MNDR-E-MI-37197 |
| MNDR | hsa-miR-30c-2-3p | Bladder cancer | MNDR-E-MI-37198 |
| MNDR | hsa-miR-30c-2-3p | Esophageal carcinoma | MNDR-E-MI-37199 |
| MNDR | hsa-miR-30c-2-3p | Parkinson disease | MNDR-E-MI-37200 |
| MNDR | hsa-miR-30c-2-3p | Breast cancer | MNDR-E-MI-37201 |
| MNDR | hsa-miR-30c-2-3p | Thyroid cancer | MNDR-E-MI-37202 |
| MNDR | hsa-miR-30c-2-3p | Pancreatic cancer | MNDR-E-MI-37203 |
| MNDR | hsa-miR-30c-2-3p | Melanoma | MNDR-E-MI-37204 |
| MNDR | hsa-miR-30c-2-3p | Rectum adenocarcinoma | MNDR-E-MI-37205 |
| MNDR | hsa-miR-30c-2-3p | Nephroblastoma | MNDR-E-MI-37206 |
| MNDR | hsa-miR-30c-2-3p | Colon cancer | MNDR-E-MI-37207 |
| MNDR | hsa-miR-30c-2-3p | Colon adenocarcinoma | MNDR-E-MI-37208 |
| MNDR | hsa-miR-30c-2-3p | Familial ovarian cancer | MNDR-E-MI-37209 |
| MNDR | hsa-miR-30c-2-3p | Prostate adenocarcinoma | MNDR-E-MI-37210 |
| MNDR | hsa-miR-30c-2-3p | Kidney cancer | MNDR-E-MI-37211 |
| MNDR | hsa-miR-30c-2-3p | Carcinoma ductal breast | MNDR-E-MI-37212 |
| MNDR | hsa-miR-30c-2-3p | Glioma | MNDR-E-MI-37213 |
| MNDR | hsa-miR-30c-2-3p | Chronic obstructive pulmonary disease | MNDR-E-MI-37214 |
| MNDR | hsa-miR-30c-2-3p | Gastric adenocarcinoma | MNDR-E-MI-37215 |
| MNDR | hsa-miR-30c-2-3p | Cervical squamous cell carcinoma | MNDR-E-MI-37216 |
| MNDR | hsa-miR-30c-2-3p | Lung squamous cell carcinoma | MNDR-E-MI-37217 |
| MNDR | hsa-miR-30c-2-3p | Non-small cell lung adenocarcinoma | MNDR-E-MI-37218 |
| MNDR | hsa-miR-30c-2-3p | Lung adenocarcinoma | MNDR-E-MI-37219 |
| MNDR | hsa-miR-30c-2-3p | Thyroid carcinoma | MNDR-E-MI-37220 |
| MNDR | hsa-miR-30c-2-3p | Bladder urothelial carcinoma | MNDR-E-MI-37221 |
| MNDR | hsa-miR-30c-2-3p | Pancreatic adenocarcinoma | MNDR-E-MI-37222 |
| MNDR | hsa-miR-30c-2-3p | Carcinoma renal cell | MNDR-E-MI-37223 |
| MNDR | hsa-miR-30c-2-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-37224 |
| MNDR | hsa-miR-30c-2-3p | Renal clear cell carcinoma | MNDR-E-MI-37225 |
| MNDR | hsa-miR-30c-2-3p | Biliary tract cancer | MNDR-E-MI-37226 |
| MNDR | hsa-miR-30c-2-3p | Cholangiocarcinoma | MNDR-E-MI-37227 |
| MNDR | hsa-miR-30c-2-3p | Lung small cell carcinoma | MNDR-E-MI-37228 |
| MNDR | hsa-miR-30c-2-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-37229 |
| MNDR | hsa-miR-30c-2-3p | Breast invasive carcinoma | MNDR-E-MI-37230 |
| MNDR | hsa-miR-30c-2-3p | Progressive supranuclear palsy | MNDR-E-MI-37231 |
| MNDR | hsa-miR-30c-2-3p | Hepatocellular carcinoma | MNDR-E-MI-37232 |
| MNDR | hsa-miR-30c-2-3p | Familiar ovarian carcinoma | MNDR-E-MI-37233 |
| MNDR | hsa-miR-30c-2-3p | Skin cutaneous melanoma | MNDR-E-MI-37234 |
| MNDR | hsa-miR-30c-2-3p | Skin melanoma | MNDR-E-MI-37235 |
| MNDR | hsa-miR-30c-2-3p | Colorectal cancer | MNDR-E-MI-37236 |
| MNDR | hsa-miR-30c-2-3p | Nasopharynx carcinoma | MNDR-E-MI-37237 |
| MNDR | hsa-miR-30c-2-3p | Nasopharyngeal cancer | MNDR-E-MI-37238 |
| MNDR | hsa-miR-30c-2-3p | Intracranial hemorrhage hypertensive | MNDR-E-MI-37239 |
| MNDR | hsa-miR-30c-2-3p | Breast cancer her3+ negative | MNDR-E-MI-37240 |
| MNDR | hsa-miR-30c-2-3p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-37241 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ATF3 | Homo sapiens | RR00155508 |
TOP